White Paper

The Role Of Change Management In Supporting Innovation In The Pharmaceutical Industry

Compliance GettyImages-1212446127

Innovation is the lifeblood of the pharmaceutical industry, occurring at every stage of the product lifecycle described in “The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)” guideline. This guideline elucidates the significance of the change management system, acknowledging variations in its application formality throughout the product lifecycle and the requirement to evaluate changes in accordance with regulatory submissions where appropriate.

Pharmaceutical companies face the challenge of balancing their adherence to the Good Manufacturing Practice (GMP) standards specified by regulatory authorities with the requirement to drive continual improvement in products, processes, and systems. Over the last decade or so, the implementation of a series of ICH guidelines has accelerated innovation throughout the lifecycle and the transfer of many aspects of change management ownership to pharmaceutical companies. This progressive regulation, combined with the advent of new manufacturing and analytical equipment and technology, has increased the emphasis on innovation and continual improvement of products, processes, and systems. Learn in detail about the impact of change management on the pharmaceutical industry and how it ensures innovations and improvements are managed effectively.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online